secwatch.observer — SEC 8-K summary
======================================

Issuer:     FATE THERAPEUTICS INC (FATE)
CIK:        0001434316
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0000950170-23-027007
Event type: leadership
Sentiment:  negative
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Fate Therapeutics CMO Dr. Wayne Chu resigns effective July 14, 2023
-------------------------------------------------------------------

- Dr. Yu-Waye (Wayne) Chu, Chief Medical Officer, resigns to pursue another opportunity.
- Resignation effective July 14, 2023; no disagreement with company operations or policies.
- No replacement named; CEO J. Scott Wolchko signed the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434316/000095017023027007/0000950170-23-027007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434316/000095017023027007/fate-20230608.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-027007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer